The risk of cardiovascular disease is dramatically increasing in Africans (black). The prothrombotic stress response contributes to atherothrombotic disease and is modulated by depressive symptom. We examined coagulation reactivity to acute mental stress and its relation to psychological well-being in Africans relative to Caucasians (white). 102 African and 165 Caucasian school teachers underwent the Stroop Color-Word Conflict test.
INTRODUCTION
Enhanced coagulation, impaired fibrinolysis, endothelial activation, and hyperactive platelets play an important role in the development of atherogenesis, atherothrombosis, and acute coronary syndromes (ACS) (1) . During acute mental stress, healthy individuals show a prothrombotic state that is viewed as an adaptive fight-flight response protecting the organism from excessive bleeding should injury occur (2, 3; for review). Fibrinogen, von Willebrand factor antigen (VWF:Ag) and D-Dimer, the latter indicating fibrin turnover, are particularly responsive to acute mental stress (4, 5) . Excessive stress procoagulant changes might potentially increase the risk of incident cardiovascular disease (CVD) and recurrent CVD events (3) . For instance, stress-induced fibrinogen increase was associated with carotid artery stiffness (6) and predicted an increase in ambulatory systolic blood pressure (SBP) over three years in healthy individuals (7) . Owing to impaired endothelial anticoagulant function, patients with atherothrombotic diseases showed greater platelet activation (8) and D-dimer increase (9) than controls free of CVD. Moreover, patients with emotional triggers like depressive feelings in the two hours before ACS onset, showed greater platelet aggregation during laboratory mental stress than patients reporting non-emotional triggers (10) .
Depressive symptoms have also been associated with stress-induced elevation in platelet reactivity (11) and D-dimer (12) in elderly subjects, thereby supporting the notion that hypercoagulability is one mechanism linking depression with an increased CVD risk (13) .
Potential ethnical differences in the acute procoagulant response to stress and their relation to depressive symptoms have not previously been explored. Such biobehavioral research seems important for urbanized Africans in whom a concerning increase in CVD can be observed, much of it being a consequence of their transition from a traditional African to a modernized "Western" lifestyle (14). For instance, in Africans, the CVD risk predicted by fibrinogen becomes stronger with an increasing degree of urbanization (15) . Moreover, subclinical atherosclerosis, as measured by increased carotid intima media thickness (CIMT), 4 was greater in Africans than in Caucasians (16) as well as in those with more severe depressive symptoms of both these ethnicities (17) .
The autonomic nervous system and hypothalamic pituitary adrenal axis are the two major physiologic stress response systems in humans. As cortisol peaks between 15 and 30 minutes after stress onset, prothrombotic changes within a few minutes of acute stress are largely governed by the sympathetic nervous system through release of catecholamines and adrenergic receptor stimulation (18, 19) . Stress-hormone mediated stimulation of vascular beta2-adrenergic receptors releases VWF from endothelial cells (19) (20) (21) . Stress-induced increases in D-dimer and in alpha-receptor activating norepinephrine are correlated with each other (5), but beta-adrenergic stimulation did not result in D-dimer increase (20) . Compared to Caucasians, Africans show a greater alpha-adrenergic vascular response, which is reflected by a greater total peripheral resistance (TPR) (22) . One specific hypothesis following from the above literature is that Africans would show greater D-dimer reactivity but lower VWF reactivity to acute stress than Caucasians. More severe depressive symptoms would hypothetically relate to greater procoagulant activity in both Africans and Caucasians.
The primary aim of this study was to investigate procoagulant reactivity between Africans and Caucasians through measurements of changes in circulating levels of VWF, fibrinogen and D-dimer to acute standardized laboratory stress. A secondary aim was to explore the association of depressive symptoms both continuously and categorically (i.e., based on a clinical cut-off level, with stress-induced coagulation changes. We further examined whether procoagulant reactivity would specifically relate to depressive mood or would rather be associated with elevated levels of general psychological distress.
MATERIALS AND METHODS

Study participants and design
The participants of this blood coagulation reactivity study were recruited as part of the For purposes of the present study, we excluded participants with a history of atherothrombotic disease (myocardial infarction, n=4; stroke, n=1), atrial fibrillation (n=16), and HIV positive status (n=18), all of which are associated with hypercoagulability at rest and/or in response to acute stress (10, 24, 25) , as well as participants with an ear temperature ≥37.5°C (n=3) because of a probable acute phase response that might increase coagulation factors like fibrinogen. Users of oral anticoagulants (n=2), aspirin (n=12), cortisone (n=3), oral contraceptives (n=21), antidepressants (n=3), anxiolytics (n=1), beta blockers (n=4), and calcium antagonists (n=12) were also excluded, as all of these might affect resting coagulation activity and/or coagulation reactivity with acute mental stress and/or mood (21, (26) (27) (28) (29) . To allow full multivariate statistical analyses, subjects with we also excluded subjects who missed data for coagulation measures (n=22), hemodynamic reactivity (n=10), psychological questionnaires (n=1), hemoglobin A1c (HbA1c) (n=1), creatinine (n=2), alcohol consumption (n=1), and physical activity (n=1). Finally, we excluded 4 participants because of excessively high D-dimer levels after stress (≥10'000 ng/ml), yielding a final study sample of 267 subjects. Excluded participants (n=142) were significantly more often Africans, women, and antihypertensive drug users, and they also had significantly higher screening systolic blood pressure (SBP), HbA1c, and gamma glutamyl transferase (-GT) levels than those included.
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The participants were admitted at 4:30 PM to the multi-bedroomed Metabolic Unit
Research Facility of the North-West University on Monday through Thursday. All received a standardized dinner at 06:00 PM after which they completed psychological questionnaires.
They had their last beverages (tea/coffee) and biscuits at 8:30 PM followed by recreational activities such as reading, watching television, or interacting socially. We also obtained information on demographic data, general health, including medication, and health behaviors.
All participants went to bed at around 10:00 PM and were woken at 05:45 AM. After the completion of anthropometric and manual BP measurements, a registered nurse obtained fasting blood samples which were handled according to standardized procedures. A sterile winged infusion set was left in situ with a heparin block (0.5ml of a Heparin SodiumFresenius 5000 IU/ml in 50ml normal saline solution; Fresenius Kabi, Port Elizabeth, South Africa) to prevent clotting. Thereafter, all participants underwent the laboratory stress. Blood collection: Citrated blood samples were taken before the Stroop to determine resting levels of coagulation measures. At 10 minutes poststress, the infusion set was thoroughly flushed with 2-3 ml of saline and the first 2 ml of blood were discarded before sampling was done for coagulation measures. Coagulation reactivity was calculated for each participant as the percentage change from the resting value.
Acute laboratory stress testing
Mental
Cardiometabolic risk factors
Body mass index: With participants in their underwear, we measured height and weight to the nearest 0.1 cm and 0.1 kg to calculate the body mass index (BMI, kg/m 2 ).
Screening blood pressure:
After 5 minutes of rest, using a stethoscope and a mercury sphygmomanometer (auscultatory method), duplicate BP readings were taken 5 minutes apart and measurements averaged to obtain screening SBP and DBP.
Blood lipids: Total cholesterol (T-C) and high-density lipoprotein cholesterol (HDL-C) levels were measured in serum with the Konelab 20i (Thermo Fisher Scientific, Vantaa, Finland). For statistical analysis, we computed the T-C/HDL-C ratio.
Hemoglobin A1c: HbA1c levels were determined by a turbidometric inhibition immunoassay method from EDTA plasma (Integra 400, Roche, Basel, Switzerland).
Renal function:
We used the Modification of Diet in Renal Disease (MDRD) Study equation to estimate glomerular filtration rate (eGFR) from creatinine levels, age, sex, and ethnicity (36) . Creatinine was measured in serum using an enzymatic colorimetric test (Cobas Integra 400 plus, Roche, Basel, Switzerland).
Health behaviors
Smoking: Participants who indicated that they currently smoked and/or had smoked at least one cigarette per day during one year in the past were categorized as ever smokers.
Alcohol consumption: Serum levels of -GT activity were used as a marker of alcohol abuse (37) and measured with an enzymatic colorimetric assay (Cobas Integra 400 plus).
Physical activity:
We used the Actical ® accelerometers (Montréal, Québec) to quantify and index physical activity with 3 (vigorous intensity), 2 (moderate intensity) or 1 (light intensity) (38) .
Coagulation measures
Blood processing: Citrated blood samples were centrifuged at 1,500 rpm (2000g) for 15 minutes at room temperature. Citrated plasma samples were aliquoted and frozen at − 80°C until analysis. Fibrinogen and D-dimer were determined by an accredited laboratory.
Von Willebrand factor: Plasma VWF:Ag (%) were measured with a "sandwich" ELISA assay. A polyclonal rabbit anti-VWF antibody and a rabbit anti -VWF-HRP antibody (DAKO, South Africa) were used to form the assay. The 6th International Standard for VWF/FVIII was used to set the standard curve against which the samples were measured (39) .
Fibrinogen: Plasma fibrinogen levels (g/l) were determined using a viscosity-based method (STA Compact, STAGO Diagnostic, Roche, France).
D-dimer:
Plasma D-dimer levels (ng/ml) were determined with an immuno-based 9 method (STA Compact, STAGO Diagnostic, Roche, France). There were respectively 47.6%
and 39.7% of D-dimer values at rest and after stress below the limit of detection (<220 ng/ml). Undetectable values were substituted using the maximum likelihood method that generates values from the lognormal distribution of uncensored data under the assumption that censored values follow a lognormal distribution.
Psychological questionnaires
Depressive symptoms: We used the 9-item Patient Health Questionnaire (PHQ-9) to measure the frequency of depressive symptoms during the prior two weeks corresponding to criteria in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (40).
Each item is rated on a 4-point scale (0="not at all", 1="several days", 2= "more than half the days", 3="nearly every day") giving a possible global score of 0-27. PHQ-9 scores ≥10 have 88% sensitivity and specificity for major depression (40) . In our sample, Cronbach's  was 0.82 for Africans and 0.84 for Caucasians for the total scale.
Psychological distress:
With the 28-item General Health Questionnaire (GHQ-28), we quantified perceived psychological distress in general related to symptoms of depression, anxiety, somatic complaints and social withdrawal over the past few weeks applying the binary scoring method. The global score provides a severity measure of total psychological distress. If exceeding the threshold of 4, subjects are classified as achieving "psychiatric caseness" (41) . In our sample, Cronbach's  for the total scale was 0.91 for Africans and 0.90 for Caucasians.
Statistical analysis
We Table 1 shows the demographic and health characteristics of the 267 study participants per ethnic group. The percentage of men was higher in Africans than in Caucasians. In terms of cardiometabolic risk factors, Africans showed higher BMI, HbA1c, and screening BPdespite using more antihypertensives -than Caucasians, while Caucasians had a higher T-C/HDL-C ratio than Africans. Of the 20 subjects who took antihypertensive medications, 9
RESULTS
Participant characteristics
had thiazide diuretics, 6 had angiotensin-converting enzyme (ACE) inhibitors, 2 had angiotensin receptor blockers (ARB), and 3 had combination therapy (i.e., thiazide diuretic plus ACE inhibitor or ARB). Regarding health behaviors, Africans were physically less active and had higher -GT indicating more alcohol abuse than Caucasians. Africans were significantly more depressed and they also perceived more distress than Caucasians. Interaction between ethnicity and psychological questionnaires: Taking into account main effects of ethnicity and PHQ-9 and GHQ-28 scores, the interaction terms between ethnicity and the continuous as well as categorical PHQ-9 and GHQ-28 scores were not significant (all p-values >0.10).
Coagulation measures at rest
Stress-induced changes across all participants
The mean level of perceived stress from the Stroop was 3.70±1.64 (range 0-7 Figure 1 illustrates these interactions. Partial correlation coefficients significantly differed between groups for VWF reactivity (p=0.035) and for fibrinogen reactivity (p=0.047). PHQ-9 scores ≥ 10 were directly correlated with VWF reactivity in Africans (r=0.149), but inversely so in Caucasians (r=-0.119). Moreover, PHQ-9 scores ≥ 10 were inversely correlated with fibrinogen reactivity in Africans (r=-0.187), but directly so in Caucasians (r=0.064).
We performed six complementary univariate analyses of covariance to test whether sympathetic activity as indicated by hemodynamic reactivity might relate to the direct association between continuous PHQ-9 scores and VWF reactivity in Africans versus
Caucasians. However, all six three-way-interactions between ethnicity, continuous PHQ-9
scores and AUC measures of any hemodynamic parameter were non-significant (all pvalues≥0.12).
DISCUSSION
The main finding from our study is that Africans showed lower procoagulant reactivity in response to standardized acute laboratory mental stress when compared with
Caucasians, controlling for a range of potentially confounding variables. Relative to Caucasians, VWF levels had increased less and fibrinogen levels had decreased more in Africans after stress relative to resting levels. One explanation for the diminished increase in VWF in Africans could be a "ceiling effect" as Africans started out with higher resting levels of VWF than Caucasians. For instance, previous studies in apparently healthy individuals reported stress-induced increases of VWF of 6%, 9%, and 30% from resting levels which were respectively 91%, 98%, and 95%, in these studies (4, 45, 46) . This amount of an increase in VWF is clearly lower than in our Caucasian subjects who showed an increase in VWF of 60% starting out from average resting values of 64%, but similar to our African subjects who showed an increase in VWF of 18% from average resting levels of 93%. In contrast, a "floor effect" in Caucasians who started out on relatively lower resting fibrinogen 15 levels might account for the greater decrease in poststress fibrinogen levels relative to resting levels in Africans. Another explanation for the blunted VWF reactivity in Africans might be their alpha-adrenergic vascular stress response, as was suggested by their increased TPR reactivity (22) . Across all participants, lower VWF reactivity correlated with both greater TPR reactivity and lower SV reactivity, the latter likely reflecting increased afterload due to elevated TPR (22) . Moreover, in Caucasians, the systemic vasodilation response during the Stroop test is largely mediated by the beta2-adrenergic receptor (47) whose stimulation through stress hormones will result in endothelial release of VWF into the circulation (19) (20) (21) .
A decrease in fibrinogen levels between rest and 10 minutes after the Stroop was seen across all study participants, and to an even greater extent in Africans than Caucasians. This is contrary to expectations, as fibrinogen levels were shown to increase in response to acute mental stress in several previous studies (2-4). The Stroop protocol provoked an average level of psychological distress that compares to similar protocols (10). However, previous studies suggest that the Stroop alone might be less effective in provoking a significant fibrinogen response (48) than combinations of the Stroop with other stressors (e.g., mental arithmetic) (45) or speech stressors (4). As there was no correlation of VWF reactivity with both fibrinogen and D-dimer reactivity in the present study, but in a previous one (49) , it is also possible that the 1-minute stressor was too short to evoke a significant fibrinogen increase with fibrin formation and degradation further downstream. Nevertheless, previous studies showed coagulation and fibrinolysis activation within 2 to 5 minutes of acute mental stress (50, 51) and infusion with the stress hormone epinephrine (52). D-dimer did not increase in a previous study that combined the Stroop with mental arithmetic (53) , but in studies that applied speech stressors to inflict social evaluative threat (5, 9). The sensitivity of the various D-dimer assays used in previous stress studies might also explain heterogeneous results (54) .
Saying that, previous stress reactivity studies also used different methods to measure fibrinogen (e.g., the functional Clauss method) (4) and VWF (e.g., enzyme-linked 16 immunosorbent assays) (46) . To our knowledge, a direct comparison of the sensitivity between different assays to detect reactivity in prothrombotic measures has not been performed, but would seem important to reconcile heterogeneous study findings.
Coagulation reactivity was specifically associated with depressive symptoms (i.e., PHQ-9 scores) as opposed to more general psychological distress (i.e., GHQ-28 scores). More severe depressive symptoms were associated with greater VWF reactivity in Africans compared with Caucasians. This concurs with the notion that depressive mood along a continuum of severity is associated with an increased risk of incident CVD and recurrent cardiac events (55) . However, poststress levels of VWF and fibrinogen were similar in Africans and Caucasians, fibrinogen decreased more in depressed Africans than depressed Caucasians, and VWF reactivity was, on the whole, lower in Africans than in Caucasians;
therefore, a depression-associated increase in CVD risk in Africans through a pathway of stress-induced VWF increase would need to be shown in prospective studies.
Ethnical differences in coagulation are still poorly understood with studies showing enhanced clotting but also increased bleeding tendency in various clinical settings in Africans compared with Caucasians (56). We found resting levels of VWF:Ag, fibrinogen, and Ddimer to be higher in Africans than Caucasians, which is in agreement with some previous studies (57) (58) (59) . Theoretically, this potential predisposition to hypercoagulability might contribute to the CVD risk in Africans. In contrast, lower increase in VWF levels and greater decrease in fibrinogen levels both with acute mental stress could be viewed a hypoactive fight-flight response (60) . As opposed to constitutively released VWF, the VWF released from the endothelium after stimulation consists of large and hemostatically highly active multimers (61) . Moreover, although not investigated in our study, acute stress also activates fibrinolysis (2, 45, 50) . Therefore, the inability to mount physiologic hypercoagulability might subject Africans to an increased risk of bleeding in fight-flight situations either upon injury or even spontaneously. Therefore, the almost absent VWF response in the non-depressed
Africans might be as harmful as the increased VWF reactivity in the depressed Africans for the maintenance of the haemostatic balance between thrombosis and haemorrhage during acute mental stress.
Rigorous selection of participants on medical characteristics to minimize confounding of coagulation measures was a strength of our study, but also might reduce generalizability of study findings to the larger African population and those with established CVD. We selected three coagulation measures that were previously shown to be stress-responsive. However, they do not cover the entire dynamics of the coagulation and fibrinolysis pathways during acute mental stress. A speech stressor inflicting social evaluative threat and measuring coagulation measures longer into the recovery period from stress might have provided additional informative data. The Stroop test provoked substantial increases in BP and HR, but
there is an ongoing debate as to whether cardiovascular reactivity data gained from standardized lab stressor are generalizable to real life situations (62) . We controlled our analysis for antihypertensive medications as a group but due to insufficient statistical power could not take into account potential class effects of the different antihypertensives on outcomes. We did not include a non-stress control group. Therefore we were unable to account for circadian changes in coagulation measures, particularly so a decrease in plasma fibrinogen levels during the morning hours. We are unable to account for the possibility that stress-related changes in clearance impacted plasma concentrations of coagulation measures.
For instance, glycosylation of VWF influences its clearance by the liver, which, moreover, occurs more rapidly in individuals with blood group O than in non-O individuals (63); unfortunately, information on ABO blood group was not available in our study. The difference in liver function between Africans and Caucasians seems not an apparent explanation for the ethnic difference in VWF reactivity because the relation between ethnicity and procoagulant reactivity persisted after adjustment for -GT activity. Data are given as means±SD or percentage values. P-value refers to group differences.
GFR, glomerular filtration rate; HDL, high-density lipoprotein 
Extra Table
What is known about this topic?
 Acute mental stress induces a hypercoagulable state that may contribute to atherothrombotic diseases.
 Depressive symptoms are associated with the procoagulant stress response.
 There are ethnic differences in coagulation between Africans and Caucasians.
What this paper adds
 Africans show lower procoagulant reactivity in response to acute laboratory mental stress than Caucasians  Explanation might be higher resting levels of coagulation factors in Africans than
Caucasians and ethnic differences in the vascular stress response.
 Depressive symptoms are associated with greater stress reactivity of von Willebrand factor in Africans relative to Caucasians.
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Figure 1: Coagulation reactivity related to ethnicity and depression
